1
|
Perino J, Ramaroson H, Ong N, Lancelot V, Bezin J, Gilleron V, Daveluy A, Tournier M. Psychoactive substance intoxication leading to general hospital admission in young and middle-aged people during and after the first lockdown. Therapie 2023:S0040-5957(23)00186-5. [PMID: 38036330 DOI: 10.1016/j.therap.2023.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 09/19/2023] [Accepted: 10/24/2023] [Indexed: 12/02/2023]
Abstract
INTRODUCTION Incidence of hospitalisations related to psychoactive substance (H-PS) intoxication has been strongly decreased during the coronavirus disease 2019 (COVID-19) pandemic especially in young adult and French region of Nouvelle-Aquitaine was mostly concerned. This study aimed to describe (i) the incidence of H-PS in Bordeaux teaching hospital during and after the first 2020 lockdown in adults aged 18-29 years or 30+ then (ii) their characteristics specifically associated with the pandemic period by comparing 2020 with 2017-2019 baseline period. MATERIAL AND METHODS This historical cohort study was conducted in adults admitted to the Bordeaux teaching hospital with main or associated diagnosis codes of intoxication with benzodiazepine, methadone, buprenorphine, codeine, morphine, heroin, cocaine, ecstasy and alcohol. Data were collected locally through the discharge database. Incidence and characteristics of H-PS were described according to patients' age, in 2020 before (01/01-16/03), during (17/03-10/05), and after the first lockdown (11/05-31/07). RESULTS Among the 5,824 stays included over the study period, PS most involved were alcohol and benzodiazepines. Compared to baseline, the decrease in H-PS's incidence was more important in young adults (-40%; nbaseline=450) in comparison to those aged 30+ (-18%; nbaseline=1,101) during the pandemic period, especially during the lockdown compared to 2017 (-59%; n2017=145 vs. -35%; n2017=166) with far decrease in alcohol and ecstasy intoxications. Seriousness of hospitalisation indications was increased regardless of age during the pandemic. Particularly in young adults, the proportion of suicides attempts increased during lockdown compared to the baseline period (almost 50% vs. 29%) and the period after lockdown was associated with 1.7 more-time road accident increased and 3 more-time fights compared with pre-lockdown period. DISCUSSION/CONCLUSION The period following lockdown should be considered at risk H-PS due to accident. Recreational use of alcohol and ecstasy could be a target for minimize serious consequences associated to PS use in young adult.
Collapse
Affiliation(s)
- Justine Perino
- Department of Medical Pharmacology, Addictovigilance Center of Bordeaux, University Hospital of Bordeaux, 33000 Bordeaux, France; Inserm, BPH, U1219, University of Bordeaux, 33000 Bordeaux, France; CHU de Bordeaux, 33000 Bordeaux, France.
| | - Hanta Ramaroson
- Service d'information médicale, unité de coordination et d'analyse de l'information médicale - département d'information médicale (UCAIM-DIM), CHU de Bordeaux, 33000 Bordeaux, France
| | - Nathalie Ong
- Service d'information médicale, unité de coordination et d'analyse de l'information médicale - département d'information médicale (UCAIM-DIM), CHU de Bordeaux, 33000 Bordeaux, France
| | | | - Julien Bezin
- Inserm, BPH, U1219, University of Bordeaux, 33000 Bordeaux, France; CHU de Bordeaux, 33000 Bordeaux, France
| | - Véronique Gilleron
- Service d'information médicale, unité de coordination et d'analyse de l'information médicale - département d'information médicale (UCAIM-DIM), CHU de Bordeaux, 33000 Bordeaux, France
| | - Amélie Daveluy
- Department of Medical Pharmacology, Addictovigilance Center of Bordeaux, University Hospital of Bordeaux, 33000 Bordeaux, France; Inserm, BPH, U1219, University of Bordeaux, 33000 Bordeaux, France
| | - Marie Tournier
- Inserm, BPH, U1219, University of Bordeaux, 33000 Bordeaux, France; Hospital Charles-Perrens, 33000 Bordeaux, France
| |
Collapse
|
2
|
Perino J, Demourgues M, Ramaroson H, Bezin J, Micallef J, Miremont-Salamé G, Frauger E, Gilleron V, Ong N, Daveluy A. Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown. Public Health 2023; 223:1-6. [PMID: 37572562 DOI: 10.1016/j.puhe.2023.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 06/20/2023] [Accepted: 07/04/2023] [Indexed: 08/14/2023]
Abstract
OBJECTIVES At the beginning of the COVID-19 pandemic, the French Addictovigilance Network drew attention to the need to facilitate access to methadone while ensuring its safe use, in order to avoid the occurrence of overdoses and deaths. The objectives of the study were to assess the impact of the lockdowns on the incidence of methadone-use-related hospitalisations (MUHs) and describe the characteristics of patients and hospitalisations. STUDY DESIGN An interrupted time series using the unobserved components model was performed to predict the monthly incidence of MUHs in 2020 on the basis of previous years' data and compared with MUHs observed. Data were presented with prediction intervals (PI95%). METHODS This retrospective study was conducted on patients hospitalised in France for methadone between 2014 and 2020, using the French national database hospital discharge database. Patients' characteristics and hospitalisations were described over four periods: before lockdown, first lockdown, after first lockdown, and second lockdown. RESULTS Compared to the predictions, a higher incidence of MUH was found during the first lockdown, especially in March 2020 (66 cases vs. 51.3; PI95%: 34-65), and there was a large increase during the month following the end of the first lockdown (79 cases vs. 61; PI95%: 46-75). Coconsumptions (alcohol, cannabis, cocaine) were more frequent during the first lockdown, whereas patients aged over 30 years were more concerned thereafter. The second lockdown did not present any particularity. CONCLUSIONS The first lockdown had a significant impact on the incidence of MUHs. These results confirm the data from the reinforced national monitoring during first lockdown published in 2020, where methadone was the primary substance involved in overdoses and deaths.
Collapse
Affiliation(s)
- J Perino
- Service de Pharmacologie Médicale, CHU de Bordeauxx, Centre de Pharmacovigilance de Bordeaux, F-33000 Bordeaux, France; University Bordeaux, INSERM, BPH, U1219, CHU de Bordeaux, F-33000 Bordeaux, France
| | - M Demourgues
- Service de Pharmacologie Médicale, CHU de Bordeauxx, Centre de Pharmacovigilance de Bordeaux, F-33000 Bordeaux, France
| | - H Ramaroson
- Service d'Information Médicale, Unité de Coordination et d'Analyse de l'Information Médicale-département d'Information Médicale (UCAIM-DIM), CHU de Bordeaux, F-33000 Bordeaux, France
| | - J Bezin
- University Bordeaux, INSERM, BPH, U1219, CHU de Bordeaux, F-33000 Bordeaux, France
| | - J Micallef
- Centre d'Addictovigilance, Aix Marseille University, AP-HM, INSERM, Institute Neuroscience System, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France
| | - G Miremont-Salamé
- Service de Pharmacologie Médicale, CHU de Bordeauxx, Centre de Pharmacovigilance de Bordeaux, F-33000 Bordeaux, France; University Bordeaux, INSERM, BPH, U1219, CHU de Bordeaux, F-33000 Bordeaux, France; Service de Pharmacologie Médicale, Centre d'Addictovigilance, CHU de Bordeaux, F-33000 Bordeaux, France
| | - E Frauger
- Centre d'Addictovigilance, Aix Marseille University, AP-HM, INSERM, Institute Neuroscience System, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France
| | - V Gilleron
- Service d'Information Médicale, Unité de Coordination et d'Analyse de l'Information Médicale-département d'Information Médicale (UCAIM-DIM), CHU de Bordeaux, F-33000 Bordeaux, France
| | - N Ong
- Service d'Information Médicale, Unité de Coordination et d'Analyse de l'Information Médicale-département d'Information Médicale (UCAIM-DIM), CHU de Bordeaux, F-33000 Bordeaux, France
| | - A Daveluy
- Service de Pharmacologie Médicale, CHU de Bordeauxx, Centre de Pharmacovigilance de Bordeaux, F-33000 Bordeaux, France; University Bordeaux, INSERM, BPH, U1219, CHU de Bordeaux, F-33000 Bordeaux, France; Service de Pharmacologie Médicale, Centre d'Addictovigilance, CHU de Bordeaux, F-33000 Bordeaux, France.
| |
Collapse
|
3
|
Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2023; 118:104082. [PMID: 37336071 PMCID: PMC10247883 DOI: 10.1016/j.drugpo.2023.104082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 05/15/2023] [Accepted: 05/29/2023] [Indexed: 06/21/2023]
Abstract
BACKGROUNDS The Covid-19 pandemic offered a unique opportunity to investigate trends in hospitalizations related to psychoactive substance intoxication, since the usual health burden of social use at parties and gatherings was likely to be decreased during lockdowns and curfew periods. Since young adults are the main users of psychoactive substances for experimental and recreational purposes, this study identified and compared hospitalization trends in young adults and adults over 30 years old. METHODS This national cohort study was conducted using the French hospital discharge database. An interrupted time-series analysis for the period between 2014 and 2020 was performed in two groups: young (age 18-29) and other adults (30+) to ascertain the trends in the monthly incidence of hospitalization related to psychoactive substance intoxication (opiates, cocaine, benzodiazepines, psychostimulants, alcohol and cannabis). Hospitalization characteristics during the first and second lockdown and the period between them were compared to the reference period (from 01/01/2014 to 29/02/2020). RESULTS Among 1,358,007 stays associated with psychoactive substance intoxication, 215,430 concerned young adults. Compared with adults 30+, hospitalization trends in young adults showed a greater decrease in the number of stays during lockdown, with a maximum decrease of -39% during the first lockdown (1,566 vs. 2,576; CI95%: 2,285-2,868) versus -20% (10,212 vs. 12,894; CI95%: 12,001-13,787) in the second lockdown. Presentations for alcohol intoxication decreased throughout the pandemic, particularly during the second lockdown, while admissions for benzodiazepine intoxication increased during both lockdowns. Admissions for cannabis intoxication increased throughout the entire period. CONCLUSIONS Lockdowns were associated with fewer hospitalizations related to psychoactive substance intoxication in both age groups, especially among young adults, which might reflect a decrease in social use. Recreational use might therefore be an important target for prevention and risk minimization.
Collapse
Affiliation(s)
- J Perino
- University hospital of Bordeaux, Centre d'addictovigilance de Bordeaux, Department of medical pharmacology, Bordeaux F-33000, France; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux F-33000, France; CHU de Bordeaux, Bordeaux, France.
| | - H Ramaroson
- Unité de Coordination et d'Analyse de l'Information Médicale, Département d'Information Médicale (Ucaim-DIM), Service D'information Médicale, Chu De Bordeaux, FR, France
| | - N Ong
- Unité de Coordination et d'Analyse de l'Information Médicale, Département d'Information Médicale (Ucaim-DIM), Service D'information Médicale, Chu De Bordeaux, FR, France
| | - J Bezin
- Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux F-33000, France; CHU de Bordeaux, Bordeaux, France
| | - V Gilleron
- Unité de Coordination et d'Analyse de l'Information Médicale, Département d'Information Médicale (Ucaim-DIM), Service D'information Médicale, Chu De Bordeaux, FR, France
| | - A Daveluy
- University hospital of Bordeaux, Centre d'addictovigilance de Bordeaux, Department of medical pharmacology, Bordeaux F-33000, France; Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux F-33000, France
| | - M Tournier
- Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux F-33000, France; Hospital Charles Perrens, Bordeaux F-33000, France
| |
Collapse
|
4
|
Eiden C, Roy S, Malafaye N, Lehmann M, Peyrière H. Ten-year trends in hospitalizations related to cocaine abuse in France. Fundam Clin Pharmacol 2022; 36:1128-1132. [PMID: 35801616 PMCID: PMC9796279 DOI: 10.1111/fcp.12815] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 05/25/2022] [Accepted: 07/06/2022] [Indexed: 01/01/2023]
Abstract
In France, the abuse/misuse of psychoactive substances, including cocaine, is monitored via spontaneous notifications, and under-reporting is its main limitation. Therefore, the French national hospital discharge database (Programme de Médicalisation des Systèmes d'information [PMSI]) was used to identify all hospital stays possibly due to complications related to cocaine use. The objective was to determine the main trends in the rate of cocaine-related hospitalizations from 2010 to 2019 by age category and by areas. Relevant PMSI data were extracted using the International Classification of Diseases (10th edition). In France, hospitalizations for cocaine-related complications increased by fourfold (2461 in 2010, 9843 in 2019, +300%). This increase was similar in men and women and was observed in each age category. Patients were mainly men (75% in 2010 and in 2019), with a median age of 38.5 and 35.2 years for men and women, respectively, in 2019. Cocaine poisoning in pediatric patients (0-9 years) concerned less than 10 patients in 2010 and 21 patients in 2019. PMSI data analysis shows an overall increase of cocaine-related hospitalizations in France from 2010 to 2019 that can be linked in part to an increasing recreational use. The increase of pediatric cases of cocaine poisoning suggests a trivialization of cocaine consumption.
Collapse
Affiliation(s)
- Céline Eiden
- Department of Medical Pharmacology and ToxicologyMontpellier University HospitalMontpellierFrance
| | - Sophie Roy
- Department of Medical Pharmacology and ToxicologyMontpellier University HospitalMontpellierFrance
| | - Nicolas Malafaye
- Department of Medical data, Health Care Processes and Cost Analysis UnitMontpellier University HospitalMontpellierFrance
| | - Michel Lehmann
- Department of Medical data, Health Care Processes and Cost Analysis UnitMontpellier University HospitalMontpellierFrance
| | - Hélène Peyrière
- Department of Medical Pharmacology and ToxicologyMontpellier University HospitalMontpellierFrance,Pathogenesis and Control of Chronic Infections, Univ Montpellier, INSERM, EFS, CHU MontpellierMontpellierFrance
| |
Collapse
|
5
|
Zakerabasali S, Kadivar M, Safdari R, Niakan Kalhori SR, Mokhtaran M, Karbasi Z, Sayarifard A. Development and validation of the Neonatal Abstinence Syndrome Minimum Data Set (NAS-MDS): a systematic review, focus group discussion, and Delphi technique. J Matern Fetal Neonatal Med 2020; 35:617-624. [PMID: 33047642 DOI: 10.1080/14767058.2020.1730319] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
OBJECTIVES Neonatal abstinence syndrome (NAS) is a combination of symptoms in infants exposed to any variety of substances in utero. Information systems and registries help to collect information about these patients; however, there is always a deep gap between complete and accurate information to be collected, understood, and applied in the health care system; thus, defining a minimum data sets (MDS) as one of the primarily steps of designing a registry system is essential. The aim of this study was to develop an MDS of the registry for infants with NAS in Iran. METHODS This research is a descriptive cross-sectional study. In this study, three steps were carried out to develop the MDS including systematic review, Delphi technique, and focus group discussion. A systematic review was conducted in relevant databases to identify appropriate related data. In the second phase, a focus group discussion was used to classify the extracted data elements by contributing neonatologists. Finally, data elements were chosen through the decision Delphi technique in two distinct rounds. Collected data were analyzed using SPSS 22 (SPSS Inc., Chicago, IL). RESULTS By reviewing related papers and available NAS registries in other countries, 145 essential data elements were identified. They were classified into two main categories based on the eight experts' opinions including maternal with two sections and infant with two sections. After applying two rounds of Delphi technique, the final data elements for maternal and infant categories were 42 and 31, respectively. Thus, on completion of the survey, 73 data elements were approved. CONCLUSION The proposed MDS for NAS can help to store an accurate and comprehensive data, document medical records, integrate them with other information systems and registries, and communicate with other healthcare providers and healthcare centers. This MDS can contribute to the provision of high-quality care and better clinical decisions.
Collapse
Affiliation(s)
- Somayyeh Zakerabasali
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Maliheh Kadivar
- Department of Pediatrics, Division of Neonatology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Reza Safdari
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Sharareh R Niakan Kalhori
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Zahra Karbasi
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Azadeh Sayarifard
- Community Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
6
|
Reprint of: The effect of the Music Day event on community drug use. Forensic Sci Int 2020; 314:110355. [PMID: 32721823 DOI: 10.1016/j.forsciint.2020.110355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Revised: 02/18/2020] [Accepted: 02/27/2020] [Indexed: 11/24/2022]
Abstract
Illicit drugs consumption can be back-calculated based on the analysis of drug residues in wastewater using the wastewater-based epidemiology method. The Music Day, held on June 21 in France since 1982, has grown to global proportions and is now celebrated as World Music Day. This large outdoor event takes place in many cities with people allowed to play music in the streets. As psychotropic drugs are often associated with music events, the goal of this study is to investigate the use of illicit drugs on this day in Bordeaux, the fifth largest urban area in France. Daily sampling campaigns of composite wastewater were carried out for seven days in two wastewater treatment plants in Bordeaux in 2017 (Music Day) and 2018. World Music Day in Bordeaux has no observable effect on illicit drug consumption even if this event has massive public participation: this is the first report of the absence of an illicit drug consumption increase in a festival of such magnitude, corroborating the effect of others' views and opinions, because this event takes place publicly in the street and not among peers. Different hypothesizes are put forward to explain this fact: inappropriate type of event for drug consumption, effect of other festivals, and influence of the event's timing on a weekday.
Collapse
|
7
|
Devault DA, Peyré A, Jaupitre O, Daveluy A, Karolak S. The effect of the Music Day event on community drug use. Forensic Sci Int 2020; 309:110226. [DOI: 10.1016/j.forsciint.2020.110226] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Revised: 02/18/2020] [Accepted: 02/27/2020] [Indexed: 11/28/2022]
|
8
|
Micallef J, Jouanjus É, Mallaret M, Lapeyre Mestre M. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]. Therapie 2019; 74:579-590. [PMID: 31694770 DOI: 10.1016/j.therap.2019.09.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 08/26/2019] [Accepted: 08/26/2019] [Indexed: 10/25/2022]
Abstract
The French Addictovigilance Network aims to monitor all psychoactive substances with abuse potential including prescription drugs and other legal and illegal substances such as new psychoactive substances (NPS) and its consequences in humans. Created in 1990 through a network of regional addictovigilance centres covering the entire country, these pharmacologists with expertise in addictovigilance have developed interface with different partners (physicians, toxicologists, network of community pharmacies, addictology care centers…) and implemented several original tools of pharmacosurveillance (such as DRAMES [death related to the abuse of medicines] in strong collaboration with toxicologists or such OPPIDUM [observation of illegal products and misuse of psychotropic medications]), complementary to the spontaneous reporting. A such multidimensional approach including proactive surveillance by these tools and also among several heterogenous data sources (such as data from hospitals or claims database) is able to detect early addictovigilance signals and warnings as illustrated with three following examples: cannabis use and acute serious cardiovascular disorders, new synthetic opioids (ocfentanil, carfentanil) and severe opiate overdose or deaths, the diverted use of psychoactive drugs (codeine analgesics or sedative H1 antihistamines called purple drank) by adolescents and young adults. The choice of a broad strategy and the multifaceted system implemented by the French Addictovigilance Network using elements of pharmacology (fundamental, clinical, pharmacoepidemiology) expertise is an innovative method to detect early addictovigilance signals, and to describe its characteristics in order to increase awareness of psychoactive substances by patients, users and health professionals.
Collapse
Affiliation(s)
- Joëlle Micallef
- UMR 1106, Inserm, service de pharmacologie clinique, centre hospitalo-universitaire de Marseille, centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, Aix-Marseille université, 13005 Marseille, France.
| | - Émilie Jouanjus
- UMR 1027 Inserm, service de pharmacologie clinique, centre hospitalo-universitaire de Toulouse, centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, université Paul-Sabatier, 31000 Toulouse, France
| | - Michel Mallaret
- Centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, centre hospitalo-universitaire de Grenoble, 38043 Grenoble, France
| | - Maryse Lapeyre Mestre
- UMR 1027 Inserm, service de pharmacologie clinique, centre hospitalo-universitaire de Toulouse, centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, université Paul-Sabatier, 31000 Toulouse, France
| |
Collapse
|
9
|
Zakerabasali S, Safdari R, Kadivar M, Rostam Niakan Kalhori S, Mokhtaran M, Karbasi Z, Sayarifard A, Abhari S. Neonatal abstinence syndrome: a systematic review of current databases and registries. J Matern Fetal Neonatal Med 2019; 34:979-992. [PMID: 31092074 DOI: 10.1080/14767058.2019.1618827] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
OBJECTIVES Registries are considered as rich sources of data for determination of infants with neonatal abstinence syndrome (NAS), the improvement of provided care and research. The aims of this study were: (1) to investigate the existing studies including NAS registries, (2) to identify and extract the required data elements. METHODS The following electronic databases were searched: PubMed, Scopus, Web of Science, ProQuest, Embase/Medline, and Psych Info. In addition, a review of gray literature was undertaken to identify relevant studies in English covering the period from 1 January 2009 to 1 November 2018 including registries and databases. Screening of titles, abstracts, and full-texts were conducted independently by two researchers based on PRISMA guidelines. The basic registry information, scope, registry type, data source, the purpose of registry, important variables were extracted and analyzed. RESULTS Twenty-five articles were eligible and included in the review; they reported 37 registries and databases related to NAS at the national and state levels in 11 countries from 1876 to 2013. We proposed a NAS registry design framework based on well-known data-information-knowledge (DIK) structure due to Ackoff's DIK hierarchy has a defined role as a central model of information systems, information management, and knowledge management. CONCLUSIONS To the best of our knowledge, this is the first study which has systematically reviewed NAS-related registries. Since there are no international standards to develop new NAS registries, the proposed framework in this article can be beneficial. This framework is essential not only to facilitate the NAS registry design but also to help the collection of high-value clinical data necessary for the acquisition of better clinical knowledge.
Collapse
Affiliation(s)
- Somayyeh Zakerabasali
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Reza Safdari
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Maliheh Kadivar
- Department of Pediatrics, Division of Neonatology, Tehran University of Medical Sciences, Tehran, Iran.,Community Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran, Iran
| | - Sharareh Rostam Niakan Kalhori
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Zahra Karbasi
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| | - Azadeh Sayarifard
- Community Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran, Iran
| | - Shahabeddin Abhari
- Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
10
|
Dupui M, Micallef J, Lapeyre-Mestre M. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution. Therapie 2019; 74:307-314. [DOI: 10.1016/j.therap.2018.09.078] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2018] [Accepted: 09/29/2018] [Indexed: 10/27/2022]
|
11
|
Barberot P, Gibaja V, Benkhedda C, Dobre D, Tournebize J, Kahn JP. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]. Therapie 2018; 74:389-397. [PMID: 30392700 DOI: 10.1016/j.therap.2018.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Revised: 09/27/2018] [Accepted: 10/08/2018] [Indexed: 10/28/2022]
Abstract
OBJECTIVES France is the only European country with a dedicated addictovigilance network (French addictovigilance network [FAN]). However, the reporting of cases of abuse/dependence is insufficient. In an attempt to overcome this under-reporting, data from the medical information systems program (PMSI) is regularly used to identify cases. Since addictions are frequently associated with psychiatric comorbidities, a pilot study was conducted for the first time in a psychiatric hospital. It aims, through a PMSI request, to identify the sociodemographic characteristics and psychiatric diagnoses of patients consuming psychoactive substances (PAS) and the PAS types consumed. METHODS This is a retrospective observational study conducted over a nine-month period at the psychotherapeutic center of Nancy (CPN). The codes used for the PMSI request are those of the international classification of diseases, tenth revision (ICD-10), codes F10 to F19 that characterize mental and behavioral disorders associated with the use of PAS. Cases presenting the four criteria necessary for an addictovigilance notification: (1) identified notifier, (2) identified patient, (3) known consumed product (s) and (4) presence of an effect related to the abuse/dependence of PAS; were retained and analyzed. RESULTS On an initial number of 252 cases, 82 cases of abuse/dependence were retained. The selected sample is predominantly male (67%). Cannabis (29%) and heroin (15%) are the most common illicit PAS. Regarding drugs, the consumption of benzodiazepines, a predominantly female phenomenon, is observed in 34% of subjects. Sixty-four per cent of the subjects were diagnosed "disorders related to the use of PAS", 14% as neurotic disorders, 9% as schizophrenia and 5% as of the mood disorders. CONCLUSION This study identified a significant number of potentially reportable cases to the French Addictovigilance Network and demonstrated the interest of investigating cases of abuse/dependence in a psychiatric hospital.
Collapse
Affiliation(s)
- Pauline Barberot
- Centre d'évaluation et d'information sur la pharmacodépendance et addictovigilance (CEIP-A), CHRU de Nancy, hôpital central, 29, avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France.
| | - Valérie Gibaja
- Centre d'évaluation et d'information sur la pharmacodépendance et addictovigilance (CEIP-A), CHRU de Nancy, hôpital central, 29, avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France; French Addictovigilance Network (FAN), 54035 Nancy, France
| | - Célia Benkhedda
- Centre d'évaluation et d'information sur la pharmacodépendance et addictovigilance (CEIP-A), CHRU de Nancy, hôpital central, 29, avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France
| | - Daniela Dobre
- Département de l'information médicale et unité de recherche et d'investigation clinique, Centre psychothérapique de Nancy, 54520 Laxou, France
| | - Juliana Tournebize
- Centre d'évaluation et d'information sur la pharmacodépendance et addictovigilance (CEIP-A), CHRU de Nancy, hôpital central, 29, avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France; French Addictovigilance Network (FAN), 54035 Nancy, France
| | - Jean-Pierre Kahn
- Centre d'évaluation et d'information sur la pharmacodépendance et addictovigilance (CEIP-A), CHRU de Nancy, hôpital central, 29, avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France; French Addictovigilance Network (FAN), 54035 Nancy, France; Unité 6, Centre psychothérapique de Nancy, pôle de psychiatrie et psychologie clinique, 54520 Laxou, France; Université de Lorraine, 54035 Nancy, France
| |
Collapse
|
12
|
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System. Drug Saf 2018; 42:559-572. [DOI: 10.1007/s40264-018-0752-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
|
13
|
Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre-Mestre M, Jouanjus E. Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clin Drug Investig 2018; 38:977-982. [DOI: 10.1007/s40261-018-0679-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
14
|
Huỳnh C, Rochette L, Pelletier É, Lesage A. Définir les troubles liés aux substances psychoactives à partir de données
administratives. SANTE MENTALE AU QUEBEC 2018. [DOI: 10.7202/1058609ar] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
15
|
Nguyen TL, Boudemaghe T, Leguelinel-Blache G, Eiden C, Kinowski JM, Le Manach Y, Peyrière H, Landais P. Identifying Life-Threatening Admissions for Drug Dependence or Abuse (ILIADDA): Derivation and Validation of a Model. Sci Rep 2017; 7:44428. [PMID: 28290530 PMCID: PMC5349588 DOI: 10.1038/srep44428] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2016] [Accepted: 02/07/2017] [Indexed: 12/23/2022] Open
Abstract
Given that drug abuse and dependence are common reasons for hospitalization, we aimed to derive and validate a model allowing early identification of life-threatening hospital admissions for drug dependence or abuse. Using the French National Hospital Discharge Data Base, we extracted 66,101 acute inpatient stays for substance abuse, dependence, mental disorders or poisoning associated with medicines or illicit drugs intake, recorded between January 1st, 2009 and December 31st, 2014. We split our study cohort at the center level to create a derivation cohort and a validation cohort. We developed a multivariate logistic model including patient's age, sex, entrance mode and diagnosis as predictors of a composite primary outcome of in-hospital death or ICU admission. A total of 2,747 (4.2%) patients died or were admitted to ICU. The risk of death or ICU admission was mainly associated with the consumption of opioids, followed by cocaine and other narcotics. Particularly, methadone poisoning was associated with a substantial risk (OR: 35.70, 95% CI [26.94-47.32], P < 0.001). In the validation cohort, our model achieved good predictive properties in terms of calibration and discrimination (c-statistic: 0.847). This allows an accurate identification of life-threatening admissions in drug users to support an early and appropriate management.
Collapse
Affiliation(s)
- Tri-Long Nguyen
- Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, UPRES EA2415, University of Montpellier, Montpellier, France.
- Laboratory of Clinical Pharmacy, Faculty of Pharmacy, University of Montpellier, Montpellier, France.
- Department of Pharmacy, Nîmes University Hospital, Nîmes, France.
| | - Thierry Boudemaghe
- Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, UPRES EA2415, University of Montpellier, Montpellier, France.
- Department of Biostatistics, Epidemiology, Public Health and Medical Informatics, Nîmes University Hospital, Nîmes, France.
| | - Géraldine Leguelinel-Blache
- Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, UPRES EA2415, University of Montpellier, Montpellier, France.
- Department of Pharmacy, Nîmes University Hospital, Nîmes, France.
| | - Céline Eiden
- Department of Medical Pharmacology and Toxicology, Addictovigilance Centre, Montpellier University Hospital, Montpellier University Hospital, Montpellier, France.
| | - Jean-Marie Kinowski
- Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, UPRES EA2415, University of Montpellier, Montpellier, France.
- Department of Pharmacy, Nîmes University Hospital, Nîmes, France.
| | - Yannick Le Manach
- Departments of Anesthesia & Clinical Epidemiology and Biostatistics, Michael DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
- The Perioperative Research Group, Population Health Research Institute, Hamilton, Ontario, Canada.
| | - Hélène Peyrière
- Laboratory of Clinical Pharmacy, Faculty of Pharmacy, University of Montpellier, Montpellier, France.
- Department of Medical Pharmacology and Toxicology, Addictovigilance Centre, Montpellier University Hospital, Montpellier University Hospital, Montpellier, France.
| | - Paul Landais
- Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, UPRES EA2415, University of Montpellier, Montpellier, France.
- Department of Biostatistics, Epidemiology, Public Health and Medical Informatics, Nîmes University Hospital, Nîmes, France.
| |
Collapse
|
16
|
Jouanjus E, Gibaja V, Kahn JP, Haramburu F, Daveluy A. Signal identification in addictovigilance: the functioning of the French system. Therapie 2015; 70:113-31. [PMID: 25858567 DOI: 10.2515/therapie/2015011] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Accepted: 09/23/2014] [Indexed: 11/20/2022]
Abstract
The French addictovigilance network (addictovigilance: surveillance of addiction), composed of 13 Addictovigilance Centres, was set up in 1990 in order to achieve reliable surveillance and evaluation of abuse and dependence cases due to psychoactive substances (alcohol and tobacco excepted). The detection of safety signals is one of the roles of the addictovigilance centres. Signals from spontaneous reports need to be analyzed before further communication. In addictovigilance, signals may be linked to adverse effects (deaths, pathological signs), to products (new psychoactive substances with potentially dangerous effects) or to practices (new administration routes, new contexts of use). These signals are provided by numerous partners among whom the addictovigilance network has to raise awareness about information that may possibly be an alert signal. The watchful attitude of all partners will make it possible that signals will be, after analyze, considered as true alerts. The addictovigilance network collects data, assess the potential for addiction of psychoactive drugs to provide information on the risk of addiction and give opinions for public health decisions (harm reduction or prevention programs, psychoactive substances control, health alerts).
Collapse
Affiliation(s)
- Emilie Jouanjus
- Centre d'Addictovigilance, Service de Pharmacologie Médicale et Clinique, CHU, Faculté de Médecine, Toulouse, France
| | - Valérie Gibaja
- Centre d'Addictovigilance, Hôpital Central, CHU de Nancy, Nancy, France
| | - Jean-Pierre Kahn
- Centre d'Addictovigilance, Hôpital Central, CHU de Nancy, Nancy, France - Service de Psychiatrie et Psychologie Clinique, Unité 6, Centre Psychothérapique de Nancy, Université de Lorraine, Laxou, France - Faculté de Médecine, Université Henri Poincaré Nancy 1, Nancy, France
| | - Françoise Haramburu
- Centre d'Addictovigilance, Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM U657, Bordeaux, France
| | - Amélie Daveluy
- Centre d'Addictovigilance, Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM U657, Bordeaux, France
| |
Collapse
|
17
|
Jouanjus E, Gibaja V, Kahn JP, Haramburu F, Daveluy A. Comment identifier un signal en addictovigilance ? Therapie 2015. [DOI: 10.2515/therapie/2015009] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
18
|
Diot C, Eiden C, Lehmann M, Sebbane M, Peyrière H. Identification and collection of abuse cases in the emergency department through a hospital database. Clin Toxicol (Phila) 2015; 53:138-9. [DOI: 10.3109/15563650.2015.1004180] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
19
|
Durrieu G, Batz A, Rousseau V, Bondon-Guitton E, Petiot D, Montastruc JL. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital. Eur J Clin Pharmacol 2014; 70:1519-26. [PMID: 25304009 DOI: 10.1007/s00228-014-1763-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2014] [Accepted: 09/29/2014] [Indexed: 10/24/2022]
Abstract
PURPOSE The aim of the study was to detect adverse drug reactions (ADRs) in pediatric inpatients using the medical administrative database "Programme de Médicalisation des Systèmes d'Information" (PMSI) and to compare these cases ADRs with those spontaneously reported to a regional PharmacoVigilance (PV) Centre. METHODS The study was conducted from January 2008 to December 2011 in the Children University Hospital of Toulouse (Midi-Pyrénées, South-west France). From PMSI database, all discharge summaries including selected ICD-10 codes (10th International Classification of Diseases) were analyzed. All ADRs spontaneously reported by the Children Hospital of Toulouse and registered in the French PV Database (FPVDB) were included. The capture-recapture method was applied to estimate the incidence of ADRs. RESULTS During the study period, we identified 60 reports from the PMSI database and 200 from the FPVDB. The rate of "serious" ADRs was higher in PMSI reports (74.6 % vs 38.9 %, p < 0.0001). The most frequent ADRs reported were musculoskeletal (12.4 %) and central (11.3 %) ADRs in PMSI database versus cutaneous (22.4 %) and general (17.5 %) ADRs in FPVDB. The most frequently suspected drugs were antineoplastic drugs (31.1 %) in PMSI database versus anti-infectives (38.2 %) in FPVDB. The estimated number of ADRs was 717 [95 % confidence interval (CI) 513, 921], and the incidence of ADRs among admissions was 0.6 % (95 % CI 0.4, 0.8). CONCLUSIONS Use of PMSI database improves from around 30 % detection of ADRs in children. In comparison with classical pharmacovigilance database, it also allows to detect different ADRs and drugs, thus enhancing safe medicine use for pediatric patients.
Collapse
Affiliation(s)
- G Durrieu
- Department of Medical and Clinical Pharmacology, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur les Médicaments, Toulouse University Hospital, Toulouse, France,
| | | | | | | | | | | |
Collapse
|